Aryx Therapeutics News
Most Popular Aryx Therapeutics Story
ARYx gets FDA nod on tecarfarin path
In an attempt to right course on the experimental blood thinner tecarfarin, ARYx Therape tics said this morning that the FDA had confirmed it is on the right development path for a regulatory Read more...
Latest Headlines
- October 31, 2011
- December 16, 2010
- August 16, 2010
- February 19, 2010
- January 5, 2010
- October 29, 2009
- October 5, 2009
- July 3, 2008
- November 7, 2007
- August 31, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
